Featured Latest news

India Approves Novo Nordisk’s Wegovy for Fatty Liver Disease Treatment

By Uniquetimesorg July 18, 2026 0

India’s drug regulator has approved Novo Nordisk’s obesity drug Wegovy for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease. The approval covers the 2.4 mg semaglutide injection and marks another significant milestone for the blockbuster drug, which is already approved in India for chronic weight Continue Reading

Featured Latest News

India’s Corporate Hubs Turn to AI for Growth

By Uniquetimesorg May 28, 2026 0

Global capability centres (GCCs) in India are increasingly using artificial intelligence to transform operations across industries, from healthcare and retail to consumer goods and finance. Companies are deploying AI to automate repetitive work in marketing, HR, finance, and content creation, helping employees save time and improve efficiency. These India-based hubs are Continue Reading

Featured Latest News

Global Companies Expand In-House Operations in India as AI Reduces Outsourcing Dependence

By Uniquetimesorg May 26, 2026 0

Global companies are increasingly shifting critical operations to their India-based centres as artificial intelligence improves productivity and reduces dependence on outsourcing vendors, executives said at a Reuters summit in Bengaluru. The trend marks a strategic shift from India serving mainly as a low-cost support base to becoming a hub for core functions such as Continue Reading

Featured Latest news

Novo Nordisk Bets Big on AI to Speed Up Drug Launches

By Uniquetimesorg May 23, 2026 0

Novo Nordisk is ramping up its use of artificial intelligence to dramatically reduce the time needed to launch new drugs, as the Danish pharmaceutical giant looks to strengthen its position in the fast-growing obesity treatment market. Speaking at a Reuters summit in Bengaluru, senior executive John Dawber said AI is helping cut months from the […]Continue Reading

Featured Latest news

Sanofi to Expand Hyderabad GCC, Workforce to Cross 4,500

By Uniquetimesorg February 17, 2026 0

French drugmaker Sanofi announced plans to expand its global capability centre (GCC) in Hyderabad, increasing its workforce to more than 4,500 employees from the current 2,600. The expansion will be backed by a multi-hundred-million-dollar investment, though the company did not disclose a specific timeline for hiring. In 2024, Sanofi had committed to investing 400 million Continue Reading

Entertainment Featured Latest News

Sun Pharma Wins Approval to Launch Generic Wegovy in India

By Uniquetimesorg January 23, 2026 0

Sun Pharmaceutical Industries, India’s largest drugmaker by revenue, has received regulatory approval to manufacture and sell a generic version of Novo Nordisk’s blockbuster weight-loss drug Wegovy in India, the company said on Friday. The generic drug, semaglutide, will be launched under the brand name Noveltreat after the expiry of Novo Nordisk’s patent in March 2026. Continue Reading

Featured Latest News

Ozempic Launches in India at Rs 2,200/Week for Type-2 Diabetes

By Uniquetimesorg December 12, 2025 0

Danish pharma giant Novo Nordisk has launched its once-weekly semaglutide injection, Ozempic, in India, priced at ₹8,800 for 0.25 mg, ₹10,170 for 0.5 mg, and ₹11,175 for 1 mg, translating to a weekly starting cost of around ₹2,200. Approved as an adjunct to diet and exercise, Ozempic is aimed at adults with type-2 diabetes with […]Continue Reading

Featured Latest News

Novo Nordisk Partners with Emcure to Launch New Weight-Loss Drug Brand ‘Poviztra’ in India

By Uniquetimesorg November 10, 2025 0

Novo Nordisk has announced an exclusive partnership with Emcure Pharmaceuticals to distribute and market its new weight-loss drug brand, Poviztra, in India. The Danish pharmaceutical giant will introduce Poviztra as a 2.4 mg semaglutide injection, representing a separate brand of its globally successful treatment, Wegovy. This strategic collaboration aims to enhance Continue Reading